resources

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA

BSE: 524715

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,746.40-24.3 (-1.37%)

14 Oct, 3:30 PM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Sun Pharmaceutical Industries Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	—	Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar
Conference Calls	—	—	—	—	—	—	—	—	2Jun 6Aug 11Nov	3Feb 2Jun 3Aug 5Nov	1Feb 31May 9Aug 8Nov	29May 7Aug 4Nov	6Feb 29May 6Aug 11Nov	4Feb 5May 29May 6Aug
Presentations	—	—	—	—	—	—	—	—	—	24Mar 16Sept	16Jan 28Apr 21Jul 11Sept	14Mar 10Jul 30Sept 28Nov	4Mar 14Jul 1Sept 26Dec	24Feb 27Apr 7Jul 22Sept

Corporate Announcements and Regulatory Filings

Sun Pharmaceutical Industries Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201814 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Confirmation Certificate
Credit Rating13 Oct 2026
Announcement under Regulation 30 (LODR)-Credit Rating
Update on Credit Ratings
Resignation of Director12 Oct 2026
Announcement under Regulation 30 (LODR)-Resignation of Director
Outcome of the Board Meeting held on 12 October 2026
Outcome of Board Meeting12 Oct 2026
Board Meeting Outcome for Outcome Of The Board Meeting Held On 12 October 2026
Outcome of the Board Meeting held on 12 October 2026
Board Meeting7 Oct 2026
Board Meeting Intimation for Consideration And Approval Of The Issuance Of Listed, Rated, Unsecured, Redeemable, Non-Convertible Debentures
Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 ,inter alia, to consider and approve the issuance ....
Press Release / Media Release6 Oct 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release
Newspaper Publication2 Oct 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication about Postal Ballot/E-voting October 2026
Postal Ballot1 Oct 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal ballot October 2026
Press Release / Media Release1 Oct 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release is enclosed
Newspaper Publication30 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication about the opening of Special Window for transfer of physical shares
General29 Sept 2026
ESG Overview For FY 2025-26
ESG Overview for FY 2025-26
General28 Sept 2026
Completion And Result Of Postal Ballot Dated 25 August 2026
Completion and Result of Postal Ballot dated 25 August 2026
Press Release / Media Release28 Sept 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release for lerodalcibep licensing agreement
General26 Sept 2026
Receipt Of Approval Of The Shareholders For Reclassification Of Shareholder Category
Receipt of approval of the shareholders for reclassification of shareholder category
Closure of Trading Window25 Sept 2026
Closure of Trading Window
Trading Window closure
General11 Sept 2026
Intimation Under Regulation 30 Of SEBI LODR
As attached
General9 Sept 2026
Incorporation Of A Subsidiary Company
Incorporation of wholly owned subsidiary of the Company in the International Financial Services Centre at GIFT City, Gandhinagar, Gujarat, India
Credit Rating8 Sept 2026
Announcement under Regulation 30 (LODR)-Credit Rating
International Credit Ratings
Analyst / Investor Meet3 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/Institutional Investor Meeting
Press Release / Media Release1 Sept 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Sun Pharma participates in White House Signing Ceremony highlighting U.S. Medicines Pricing and Access Commitments

Frequently Asked Questions

Where can I download the annual report of Sun Pharmaceutical Industries Ltd.?

Annual reports of Sun Pharmaceutical Industries Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Sun Pharmaceutical Industries Ltd.?

Quarterly earnings results and presentations of Sun Pharmaceutical Industries Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Sun Pharmaceutical Industries Ltd. publish earnings call transcripts?

Earnings call transcripts of Sun Pharmaceutical Industries Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Sun Pharmaceutical Industries Ltd.?

Investor presentations and annual day presentations of Sun Pharmaceutical Industries Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Sun Pharmaceutical Industries Ltd.?

Corporate announcements and regulatory filings of Sun Pharmaceutical Industries Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Sun Pharmaceutical Industries Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Sun Pharmaceutical Industries Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Sun Pharmaceutical Industries Ltd.?

The ISIN (International Securities Identification Number) of Sun Pharmaceutical Industries Ltd. is INE044A01036. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Sun Pharmaceutical Industries Ltd. listed?

Sun Pharmaceutical Industries Ltd. is listed on NSE and BSE. The NSE symbol is SUNPHARMA and the BSE code is -.

Where can I find the shareholding pattern of Sun Pharmaceutical Industries Ltd.?

The quarterly shareholding pattern of Sun Pharmaceutical Industries Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Sun Pharmaceutical Industries Ltd. on Sharpely?

Share price data for Sun Pharmaceutical Industries Ltd. is updated as of 14 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.